NATtrol SARS-COV-2 (recombinant) Stock
NATtrol SARS-CoV-2 (recombinant) Stock is formulated with purified, intact bacterial cells containing synthetic SARS-CoV-2 sequence. The cells have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol SARS-CoV-2 (recombinant) Stock in a purified protein matrix. NATtrol SARS-Cov-2 (recombinant) Stock is designed to evaluate the performance of nucleic…